Services include its proprietary Target Immobilised NMR Screening (TINS) for screening of fragment libraries. TINS is characterised by unparalleled sensitivity and reliability. ZoBio furthermore offers orthogonal hit validation/characterisation/elaboration support using a combination of TINS, protein observed NMR (HSQC) and Surface Plasmon Resonance.
Finally, ZoBio uniquely offers NMR-based structural biology when X-ray diffraction fails. ZoBio supports projects from hit discovery to advanced lead or even further.